openPR Logo
Press release

Complex Regional Pain Syndrome (CRPS) Therapeutics Clinical Trials & Results | Axsome Therapeutics, Inc., Grünenthal Group

Complex Regional Pain Syndrome (CRPS) Therapeutics Clinical

Complex regional pain syndrome (CRPS) is a type of chronic pain that affects one limb of the body (hand, leg, arm, or foot). The condition generally arises due to severe injuries or malfunctioning of central and peripheral nervous systems.

Download the sample report @ https://www.pharmaproff.com/request-sample/1096

CRPS is categorized into two main types: CRPS-I and CRPS-II. CRPS-I is associated with unconfirmed nerve injury; whereas, CRPS-II is associated with confirmed nerve injury. CRPS can be characterized by ‘pins and needles’, or ‘burning sensation’; or it feels like someone squeezing the affected limb. People having CRPS generally experience change in skin color and temperature, and swelling in the affected area.

Get the detailed analysis @ https://www.pharmaproff.com/report/crps-therapeutics-pipeline-analysis

Axsome Therapeutics Inc., and Grünenthal Group are two major companies involved in the development of drugs for the management of CRPS. The Grünenthal Group is in the process of developing T121, a bone resorption inhibitor, for the treatment of CRPS. Axsome Therapeutics Inc. is also developing AXS-02 as a bone resorption factor inhibitor for the treatment of CRPS.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1096

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Complex Regional Pain Syndrome (CRPS) Therapeutics Clinical Trials & Results | Axsome Therapeutics, Inc., Grünenthal Group here

News-ID: 1752003 • Views: 443

More Releases for CRPS

Complex Regional Pain Syndrome Market By Therapy Type, By Route of Administratio …
Complex Regional Pain Syndrome (CRPS) is a chronic condition that causes severe pain in legs, arms, feet, and hands or may involve the entire body. CRPS is commonly of two types, with similar symptoms and treatment. If Complex Regional Pain syndrome occurs after an injury without any nerve damage, it is known as Type I CRPS (also known as reflex sympathetic dystrophy). Type II CRPS occurs after a specific nerve
Complex Regional Pain Syndrome (CRPS) Therapeutics Market Future Opportunities 2 …
Complex regional pain syndrome is a debilitating chronic pain condition causing intense pain particularly in the arms, hands, legs, or feet. This syndrome is characterized by pain, swelling, vasomotor instability, limited range of motion, skin color changes and patchy bone demineralization. CRPS is often regarded to be caused as a result of malfunction of failure of peripheral and central nervous system and therefore also sometimes referred as reflex sympathetic dystrophy
Complex Regional Pain Syndrome (CRPS) Therapeutics Market to Reflect Impressive …
Complex regional pain syndrome is a debilitating chronic pain condition causing intense pain particularly in the arms, hands, legs, or feet. This syndrome is characterized by pain, swelling, vasomotor instability, limited range of motion, skin color changes and patchy bone demineralization. CRPS is often regarded to be caused as a result of malfunction of failure of peripheral and central nervous system and therefore also sometimes referred as reflex sympathetic dystrophy
Global Complex Regional Pain Syndrome (CRPS) Therapeutics Market to Register Sub …
Complex regional pain syndrome is a debilitating chronic pain condition causing intense pain particularly in the arms, hands, legs, or feet. This syndrome is characterized by pain, swelling, vasomotor instability, limited range of motion, skin color changes and patchy bone demineralization. CRPS is often regarded to be caused as a result of malfunction of failure of peripheral and central nervous system and therefore also sometimes referred as reflex sympathetic dystrophy
Complex Regional Pain Syndrome (CRPS) Therapeutics Market - Competitive Dynamics …
Complex regional pain syndrome is a debilitating chronic pain condition causing intense pain particularly in the arms, hands, legs, or feet. This syndrome is characterized by pain, swelling, vasomotor instability, limited range of motion, skin color changes and patchy bone demineralization. CRPS is often regarded to be caused as a result of malfunction of failure of peripheral and central nervous system and therefore also sometimes referred as reflex sympathetic dystrophy
Complex Regional Pain Syndrome (CRPS) Therapeutics Market - Global Industry Anal …
Albany, NY, 20 JAN : Presently there is no cure for the disease but drug therapies help in alleviating the pain associated with the disease as wells reduce the progression of the disease. Multimodal therapy is prescribed for the treatment of chronic regional pain syndrome which includes psychotherapy, rehabilitation therapy and drug therapy. Drug therapy for CRPS includes non-steroidal anti-inflammatory drugs (aspirin, ibuprofen, and naproxen) used to treat moderate pain